Physician profile
David Michael Neskey
NPI 1366694218
$3,965.57
in general payments reported to CMS, 2019-2025
22 companies · $287 in 2025
The $287 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.33 · 2020: $1,940 · 2021: $121 · 2022: $440 · 2023: $434 · 2024: $725 · 2025: $287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,446.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,445.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $1,940.00 | 2020 | |
| Acera Surgical, INC. | $861.04 | 2022-2025 | Restrata Wound Matrix |
| Stryker Corporation | $308.96 | 2021-2022 | |
| Forte Bio-Pharma LLC | $95.68 | 2023-2024 | Prolate, Nalocet |
| Inspire Medical Systems, INC. | $92.74 | 2024 | Inspire |
| Tactile Systems Technology INC | $91.35 | 2022-2025 | Flexitouch Plus, Nimbl |
| Olympus America INC. | $83.41 | 2023 | Olympus, Rhino-Laryngo Videoscope |
| Hologic Sales and Service, LLC | $58.70 | 2025 | Coolseal Generator |
| Integra Lifesciences Corporation | $50.34 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Axogen | $49.72 | 2023-2025 | Avance Nerve Graft |
| Aroa Biosurgery Incorporated | $44.46 | 2022-2025 | |
| Polynovo North America LLC | $43.16 | 2023-2024 | Novosorb Btm |
| Access Pro Medical, LLC | $37.58 | 2023 | Matriderm |
| Straumann USA LLC | $37.25 | 2025 | |
| Ethicon US, LLC | $36.50 | 2024 | Vistaseal, Surgicel Nu-Knit, Harmonic |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $33.28 | 2019-2022 | |
| Ambu INC. | $30.73 | 2024 | |
| Sanara Medtech INC. | $20.10 | 2025 | Celleraterx |
| Medtronic, INC. | $17.87 | 2025 | Plasmablade(Tm) |
| Smith+Nephew, INC. | $17.56 | 2022 | |
| Depuy Synthes Sales INC. | $15.14 | 2025 | Vivigen Mis Delivery System, Trumatch, Matrixmandible |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Neskey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.